These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20016672)

  • 21. Capreomycin resistance prediction in two species of Mycobacterium using a stacked ensemble method.
    Chowdhury AS; Khaledian E; Broschat SL
    J Appl Microbiol; 2019 Dec; 127(6):1656-1664. PubMed ID: 31419358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristic genes in THP‑1 derived macrophages infected with Mycobacterium tuberculosis H37Rv strain identified by integrating bioinformatics methods.
    Zhang YW; Lin Y; Yu HY; Tian RN; Li F
    Int J Mol Med; 2019 Oct; 44(4):1243-1254. PubMed ID: 31364746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and regulatory networks of Mycobacterium tuberculosis PE/PPE family antigens.
    Li W; Deng W; Xie J
    J Cell Physiol; 2019 Jun; 234(6):7742-7751. PubMed ID: 30478834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Bioinformatics Analysis of Comparative Genomics of
    Jia X; Yang L; Dong M; Chen S; Lv L; Cao D; Fu J; Yang T; Zhang J; Zhang X; Shang Y; Wang G; Sheng Y; Huang H; Chen F
    Front Cell Infect Microbiol; 2017; 7():88. PubMed ID: 28377903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional regulation of Mycobacterium tuberculosis PE/PPE genes: a molecular switch to virulence?
    Mohareer K; Tundup S; Hasnain SE
    J Mol Microbiol Biotechnol; 2011; 21(3-4):97-109. PubMed ID: 22286037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome sequence data of
    Daniyarov A; Molkenov A; Rakhimova S; Akhmetova A; Nurkina Z; Yerezhepov D; Chingissova L; Bismilda V; Toxanbaeva B; Akilzhanova A; Kozhamkulov U; Kairov U
    Data Brief; 2020 Dec; 33():106416. PubMed ID: 33102665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PE and PPE proteins of Mycobacterium tuberculosis.
    Mukhopadhyay S; Balaji KN
    Tuberculosis (Edinb); 2011 Sep; 91(5):441-7. PubMed ID: 21527209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clusters of PE and PPE genes of Mycobacterium tuberculosis are organized in operons: evidence that PE Rv2431c is co-transcribed with PPE Rv2430c and their gene products interact with each other.
    Tundup S; Akhter Y; Thiagarajan D; Hasnain SE
    FEBS Lett; 2006 Feb; 580(5):1285-93. PubMed ID: 16458305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Serum Potassium, MagnEsium, and Calcium Levels between Kanamycin and Capreomycin-BASEd Regimen-Treated MultiDrug-Resistant TuBerculosis Patients in Bandung (CEASE MDR-TB): A Retrospective Cohort Study.
    Soeroto AY; Darmawan G; Supriyadi R; Bhaskara PG; Santoso P; Alisjahbana B; Parwati I
    Int J Microbiol; 2019; 2019():5065847. PubMed ID: 31001341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis.
    Zhao J; Wei W; Yan H; Zhou Y; Li Z; Chen Y; Zhang C; Zeng J; Chen T; Zhou L
    Int J Med Microbiol; 2019 Nov; 309(7):151323. PubMed ID: 31279617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    Lobie TA; Woldeamanuel Y; Asrat D; Beyene D; Bjørås M; Aseffa A
    PLoS One; 2020; 15(4):e0231320. PubMed ID: 32267877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis.
    Pietersen E; Peter J; Streicher E; Sirgel F; Rockwood N; Mastrapa B; Te Riele J; Davids M; van Helden P; Warren R; Dheda K
    PLoS One; 2015; 10(4):e0123655. PubMed ID: 25909847
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Dijkstra JA; van der Laan T; Akkerman OW; Bolhuis MS; de Lange WCM; Kosterink JGW; van der Werf TS; Alffenaar JWC; van Soolingen D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High throughput crystallography of TB drug targets.
    Murillo AC; Li HY; Alber T; Baker EN; Berger JM; Cherney LT; Cherney MM; Cho YS; Eisenberg D; Garen CR; Goulding CW; Hung LW; Ioerger TR; Jacobs WR; James MN; Kim C; Krieger I; Lott JS; Sankaranarayanan R; Segelke BW; Terwilliger TC; Wang F; Wang S; Sacchettini JC
    Infect Disord Drug Targets; 2007 Jun; 7(2):127-39. PubMed ID: 17970224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.